Host cell glycosylation of viral glycoproteins - A battlefield for host defence and viral resistance

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 5, 1998, Pages 435-440

  Olofsson, Sigvard ^a   Hansen, John Erik S ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GLYCAN; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

GLYCOSYLATION; HOST CELL; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; LYMPHOCYTE; REVIEW; VIRUS RESISTANCE;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; GLYCOSYLATION; HUMANS; VIRAL ENVELOPE PROTEINS; VIRUS DISEASES; VIRUSES;

EID: 0032444735     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549850161386     Document Type: Review

References (39)

1. Deryckere F, Burgert HG. Early region 3 (E3) of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and C. J Virol 1996; 70: 2832-41.
2. Tiggs MA, Leng S, Johnson DC, Burke RL. Human herpes simplex virus (HSV)-specific CD8 + CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J Immunol 1996; 156: 3901-10.
3. Datema R, Olofsson S, Romero P. Inhibitors of protein glycosylation and glycoprotein processing in viral systems. Pharmac Ther 1987; 33: 221-86.
4. Roseman S. Complex carbohydrates and intercellular adhesion. In: Lee EYC, Smith EE, eds. Biology and chemistry of eucaryotic cell surfaces. New York: Academic Press 1974: 317-54.
5. Losick R, Robbins PW. Mechanism of epsilon-15 conversion studied with a bacterial mutant. J Mol Biol 1967; 30: 445-55.
6. O'Reilly DR, Miller RK. A baculovirus blocks insect molting by producing ecdysteroid UDP-glucosyl transferase. Science 1989; 245: 1110-2.
7. Kozutsumi Y, Segal M, Normington K, Gething MJ, Sambrook J. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 1988; 332: 462-4.
8. Hurtley SM, Bole DG, Hoover-Litty H, Helenius A, Copeland CS. Interactions of misfolded influenza virus hemagglutinin with binding protein (BiP). J Cell Biol 1989; 108: 2117-26.
9. Hansen JE. Carbohydrates of human immunodeficiency virus. APMIS 1992; Suppl 27: 96-108.
10. Olofsson S. Carbohydrates in herpesvirus infections. APMIS 1992; 100: 84-95.
11. Skehel JJ, Stevens DJ, Daniels RS, Douglas HR, Knossow M, Wilson IA, Wiley DC. A carbohydrate side chain on hemagglutinin of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci USA 1984; 81: 1779-83.
12. Munk K, Pritzer E, Kretzschmar E, Gutte B, Garten W, Klenk HD. Carbohydrate masking of an antigenic epitope of influenza virus haemagglutinin independent of oligosaccharide size. Glycobiology 1992; 2: 233-40.
13. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, Gregory TJ. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 1990; 265: 10373-82.
14. Geyer H, Holschbach C, Hunsmann G. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein gp120. J Biol Chem 1988; 263: 11760-7.
15. Levy JA. Pathogenesis of human immunideficiency virus. Microbiolog Rev 1993; 57: 183-289.
16. Schønning K, Jansson B, Olofsson S, Hansen J-ES. Rapid selection of an N-linked oligosaccharide by monoclonal antibodies against the V3-loop of HIV-1. J Gen Virol 1996; 77: 753-8.
17. Schønning K, Jansson B, Olofsson S, Nielsen JO, Hansen J-ES. Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quartenary structure of the HIV-1 envelope oligomer. Virology 1996; 218: 134-40.
18. Arendrup M, Sönnerborg A, Åkerblom L, Nielsen C, Clausen H, Nielsen JO, Olofsson S, Hansen J-ES. Neutralization antibody response during HIV-1 infection: type- and group-specificity and viral escape. J Gen Virol 1993; 74: 855-63.
19. Myers G, Korber B, Berzofsky JA, Smith RF, Pavlakis GN. Los Alamos. Los Alamos National Laboratory, 1992.
20. Clausen H, Bennett EP, Dabelsteen E. Carbohydrates of the cell surface: molecular aspects of glycosyl transferases and their genes. APMIS 1992; 100: 9-17.
21. Adachi M, Hayami M, Kashiwagi N, Mizuta T, Ohta Gill MJ, Matheson DS, Tamaoki T, Shiozawa C, Hakomori S-I. Expression of Ley antigen in human immunodeficiency virus-infected human T-cell lines and in peripheral lymphocytes of patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex. J Exp Med 1988; 167: 323-31.
22. Hansen JE, Clausen H, Nielsen C, Teglbjaerg LS, Hansen LL, Nielsen CM, Dabelsteen E, Mathiesen L, Hakomori SI, Nielsen JO. Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization. J Virol 1990; 64: 2833-40.
23. Hansen J-ES, Nielsen C, Arendrup M, Olofsson S, Mathiesen LR, Nielsen JO, Clausen H. Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus. J Virol 1991; 65: 6461-7.
24. Miyoshi E, Nishikawa A, Ihara Y, Hayashi N, Fusamoto H, Kamada T, Taniguchi N. Selective suppression of N-acetylglucosaminyltransferase III activity in a human hepatoblastoma cell line transfected with hepatitis B virus. Cancer Res 1994; 54: 1854-8.
25. Löwer J, Davidson E, Teich NM, Weiss RA, Joseph AP, Kurth R. Heterophil antibodies recognize oncovirus envelope antigens: epidemiological parameters and immunological specificity of the reaction. Virology 1981; 109: 409-17.
26. Klenk H-D. Influence of glycosylation on antigenicity of viral proteins. In: van Regenmortel MHV, Neurath AR, eds. The basis for serodiagnosis and vaccins. Amsterdam: Elsevier, 1990: 25-37.
27. Boccardi V, Attina D, Girelli G. Influnece of orally administered antibiotocs on anti-T agglutinin of normal subjects and of cirrhotic patients. Vox sanguinis 1974; 27: 268-72.
28. Takeuchi Y, Porter CD, Strahan KM, Preece AF, Gustafsson K, Cosset FL, Weiss RA, Collins MK. Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase. Nature 1996; 379: 85-8.
29. Galili U, Swanson K. Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci USA 1991; 88: 7401-4.
30. Welsh RMJ, Cooper NR, Jensen FC, Oldstone MB. Human serum lyses RNA tumour viruses. Nature 1975; 257: 612-4.
31. Galili U, Mandrell RE, Hamadeh RM, Shohet SB, Griffiss JM. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 1988; 56: 1730-7.
32. Repik PM, Strizki JM, Galili U. Differential host dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model. J Gen Virol 1994; 75: 1177-81.
33. Bach FH, Robson SC, Winkler H, Ferran C, Stuhlmeier KM, Wrighton CJ, Hancock WW. Barriers to xenotransplantation. Nature Med 1995; 1: 869-73.
34. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997; 3: 282-6.
35. Weiss R. Transgenic pigs and virus adaption. Nature 1998; 391: 327-8.
36. Matthews TJ, Langlois A, Robey WG, Chang NT, Gallo RC, Fischinger PJ, Bolognesi DP. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci USA 1986; 83: 513-8.
37. Rother RP, Fodor WL, Springhorn JP, Birks CW, Setter E, Sandrin MS, Squinto SP, Rollins SA. A novel mechanism of retrovirus inactivation in human serum mediated by antigalactosyl natural antibody. J Exp Med 1995; 182: 1345-55.
38. Olofsson S, Jeansson S, Hansen J-ES. Use of lectins in general and diagnostic virology. In: Doyle, RJ, Slifkin, M, eds. Lectin-microrganism interactions. New York: Marcel Dekker Inc, 1994:67-109.
39. Arendup M, Hansen JE, Clausen H, Nielsen C, Mathiesen LR, Nielson JO. Antibody to histo-blood group A antigen neutralizes HIV produced by lymphocytes from blood group A donors but not from blood group B or O donors. AIDS 1991; 5: 441-4.